139 related articles for article (PubMed ID: 38616207)
21. Locoregional and Distant Outcomes in Women With cT1-3N1 Breast Cancer Treated With Neoadjuvant Chemotherapy With or Without Adjuvant Radiotherapy.
Kozak MM; von Eyben R; Gutkin PM; Vemuri M; Jacobson CE; Karl JJ; Walck E; Marquez C; Horst KC
Clin Breast Cancer; 2021 Aug; 21(4):373-382. PubMed ID: 33766533
[TBL] [Abstract][Full Text] [Related]
22. Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy.
Wu SG; Sun JY; Zhou J; Li FY; Zhou H; Lin Q; Lin HX; Bao Y; He ZY
Radiat Oncol; 2014 Dec; 9():284. PubMed ID: 25511525
[TBL] [Abstract][Full Text] [Related]
23. Postmastectomy Radiation in Breast Cancer Patients With Pathologically Positive Lymph Nodes After Neoadjuvant Chemotherapy: Usage Rates and Survival Trends.
Ohri N; Moshier E; Ho A; Green S; Rhome R; Mazumdar M; Powell S; Tsai CJ
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):549-559. PubMed ID: 29280449
[TBL] [Abstract][Full Text] [Related]
24. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
[TBL] [Abstract][Full Text] [Related]
25. Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.
Nagar H; Mittendorf EA; Strom EA; Perkins GH; Oh JL; Tereffe W; Woodward WA; Gonzalez-Angulo AM; Hunt KK; Buchholz TA; Yu TK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):782-7. PubMed ID: 21885207
[TBL] [Abstract][Full Text] [Related]
26. Patterns of postmastectomy radiation therapy in clinically node-positive breast cancerpatients with pathologically negative lymph nodes after neoadjuvant chemotherapy.
Sayan M; Vergalasova I; George M; Kowzun M; Potdevin L; Kumar S; Haffty B; Ohri N
Turk J Med Sci; 2022 Apr; 52(2):279-285. PubMed ID: 36161617
[TBL] [Abstract][Full Text] [Related]
27. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy.
Garg AK; Oh JL; Oswald MJ; Huang E; Strom EA; Perkins GH; Woodward WA; Yu TK; Tereffe W; Meric-Bernstam F; Hahn K; Buchholz TA
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1478-83. PubMed ID: 17855016
[TBL] [Abstract][Full Text] [Related]
28. The Value of the 8th Edition of American Joint Committee on Cancer Pathological Prognostic Staging on the Selection of Postmastectomy Radiotherapy for T1-2N1 Breast Cancer.
Wang J; Zhong XR; Luo T; Xiang ZZ; Zeng YY; Yang T; Zheng H; Liu L
J Oncol; 2022; 2022():7550323. PubMed ID: 36330354
[TBL] [Abstract][Full Text] [Related]
29. Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials.
Saifi O; Bachir B; Panoff J; Poortmans P; Zeidan YH
Radiother Oncol; 2023 Jul; 184():109668. PubMed ID: 37030399
[TBL] [Abstract][Full Text] [Related]
30. Post-mastectomy radiation therapy and overall survival after neoadjuvant chemotherapy.
Kantor O; Pesce C; Singh P; Miller M; Tseng J; Wang CH; Winchester DJ; Yao K
J Surg Oncol; 2017 May; 115(6):668-676. PubMed ID: 28083910
[TBL] [Abstract][Full Text] [Related]
31. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
32. Is postmastectomy radiotherapy really needed in breast cancer patients with many positive axillary lymph nodes?
Marinko T; Stanic K
Radiol Oncol; 2018 Mar; 52(3):275-280. PubMed ID: 30210045
[TBL] [Abstract][Full Text] [Related]
33. Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease : An individual patient data analysis of three clinical trials.
Abdel-Rahman O
Strahlenther Onkol; 2019 Apr; 195(4):297-305. PubMed ID: 30069737
[TBL] [Abstract][Full Text] [Related]
34. Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.
Miyashita M; Tada H; Suzuki A; Watanabe G; Hirakawa H; Amari M; Kakugawa Y; Kawai M; Furuta A; Sato K; Yoshida R; Ebata A; Sasano H; Jingu K; Ohuchi N; Ishida T
Surg Oncol; 2017 Jun; 26(2):163-170. PubMed ID: 28577722
[TBL] [Abstract][Full Text] [Related]
35. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
[TBL] [Abstract][Full Text] [Related]
36. Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy: A prelude to NSABP B-51?
Haque W; Singh A; Verma V; Schwartz MR; Chevli N; Hatch S; Desai M; Butler EB; Arentz C; Farach A; Teh BS
Radiother Oncol; 2021 Sep; 162():52-59. PubMed ID: 34214615
[TBL] [Abstract][Full Text] [Related]
37. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
38. Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancers.
Francis SR; Frandsen J; Kokeny KE; Gaffney DK; Poppe MM
Breast; 2017 Apr; 32():156-161. PubMed ID: 28193571
[TBL] [Abstract][Full Text] [Related]
39. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
40. Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418).
Kim YJ; Park W; Ha B; Park B; Joo J; Kim TH; Park IH; Lee KS; Lee ES; Shin KH; Kim H; Yu JI; Choi DH; Huh SJ; Wee CW; Kim K; Park KR; Kim YB; Ahn SJ; Lee JH; Kim JH; Chun M; Lee HS; Kim JS; Cha J
Cancer Res Treat; 2017 Oct; 49(4):927-936. PubMed ID: 28052654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
